Jaguar Uranium Corp. filings document the company's public-company status, capital structure, and mineral exploration disclosures. The filing record includes Form 8-K reporting tied to the company's initial public offering of Class A common shares, related share issuances, and its status as an emerging growth company.
The company's registration and disclosure materials also address its uranium exploration portfolio, risk factors, and securities structure, including risks associated with uranium prices, exploration and development, geological interpretation, permitting, regulation, political conditions, community matters, and currency fluctuations.
Jaguar Uranium Corp. reported its first quarter as a public company, showing a much larger net loss as it completed its NYSE American IPO. Net loss for the three months ended March 31, 2026 was $19,868,637, compared with $513,416 a year earlier, with no revenue in either period.
The loss was driven mainly by $17,747,028 of Liquidity Event and Listing Event Shares and a $720,700 deferred cash payment tied to prior acquisitions, rather than core operating costs. Operating expenses were $1,421,924, reflecting higher general and administrative spending, professional fees, and exploration work in Colombia and Argentina.
On February 11, 2026, Jaguar completed its IPO, issuing 6,250,000 common shares at $4 per share for gross proceeds of $25,000,000 and net proceeds of $22,725,000. Cash and cash equivalents rose to $20,155,926 as of March 31, 2026, and total assets increased to $28,548,607, including $8,150,000 of mineral properties. Management expects the IPO proceeds to fund planned exploration and corporate activities for approximately 24 months.
Jaguar Corp. (Jaguar Uranium) files its annual report as an exploration-stage uranium company with no production or mining revenue. The business centers on three early-stage projects: the Berlin Project in Colombia and the Laguna and Huemul projects in Argentina, all lacking defined mineral reserves under S-K 1300.
The company raised about $22.7 million of net IPO proceeds to fund roughly two years of initial exploration and pre-extraction work but reports continued losses, accumulated deficit and working capital deficits as of December 31, 2025. It warns that substantial additional equity or debt financing will be required to advance permitting, drilling, metallurgy, pilot plants and economic studies.
Jaguar outlines extensive regulatory regimes in Colombia and Argentina, including concession fees, environmental insurance, impact assessments, royalties and provincial mining codes. The filing highlights favorable long-term uranium market fundamentals and nuclear demand growth but stresses significant operational, jurisdictional, environmental, title, competition and price risks that could prevent its projects from ever reaching profitable commercial production.
IsoEnergy Ltd. and its wholly owned subsidiary Consolidated Uranium Inc. report significant ownership in Jaguar Uranium Corp. Class A common shares. Together they beneficially own 3,253,150 shares, representing 16.1% of Jaguar Uranium’s 20,193,777 shares outstanding as of February 12, 2026.
IsoEnergy holds sole voting and dispositive power over 253,150 shares and shared power over 3,000,000 shares through Consolidated Uranium, which itself reports a 14.9% stake. Part of the position came from Jaguar’s initial public offering for cash consideration of $1,014,000, with additional shares issued in exchange for mining assets and as further consideration under contractual arrangements.
IsoEnergy has an investor rights agreement giving it participation rights in future equity financings on terms consistent with other investors and the right to nominate one Jaguar board member, which ends if its ownership falls below 5%. Consolidated Uranium’s share purchase agreement provided 2,000,000 shares, net smelter returns royalties and rights to receive additional shares in certain circumstances.
IsoEnergy Ltd., a more than 10% holder of Jaguar Uranium Corp., reported several Class A common share transactions. On February 12, 2026, Consolidated Uranium Inc., IsoEnergy’s wholly owned subsidiary, received 1,000,000 Jaguar Uranium Class A common shares at deemed prices of $5.00 and $4.00 per share under a Share Purchase Agreement dated July 17, 2024, after certain conditions were satisfied, resulting in 3,000,000 shares held indirectly. On February 11, 2026, IsoEnergy directly bought 253,150 Class A common shares at $4.00 per share in an open-market or private transaction and held 253,150 shares directly afterward.
IsoEnergy Ltd., a 10% owner of Jaguar Uranium Corp., reported multiple transactions in Class A common shares. On February 12, 2026, Consolidated Uranium Inc., IsoEnergy’s wholly owned subsidiary, received 1,000,000 shares at deemed prices of $5.00 and $4.00 per share under a Share Purchase Agreement dated July 17, 2024, upon satisfaction of specified conditions. These shares are owned directly by Consolidated Uranium, making IsoEnergy an indirect beneficial owner. On February 11, 2026, IsoEnergy separately made an open-market or private purchase of 250,000 Class A common shares at $4.00 per share, resulting in 250,000 shares held directly after that trade and 3,000,000 shares held indirectly following the subsidiary’s receipt.
Jaguar Uranium Corp. disclosed an initial insider ownership report showing that IsoEnergy Ltd. is a ten percent owner of Jaguar Uranium. The filing reports indirect beneficial ownership of 2,000,000 Class A common shares of Jaguar Uranium through Consolidated Uranium Inc., a wholly owned subsidiary of IsoEnergy.
This Form 3 does not report a new purchase or sale of shares. Instead, it records IsoEnergy’s existing indirect stake in Jaguar Uranium, providing transparency about significant shareholders and their level of ownership in the company’s Class A common shares.
Jaguar Uranium Corp. completed its initial public offering of 6,250,000 Class A common shares at $4.00 per share, generating gross proceeds of $25,000,000 before underwriting discounts and expenses. The company also granted the underwriter a 30-day option to buy up to 937,500 additional shares to cover any over-allotments.
In connection with previously disclosed transactions, Jaguar Uranium issued 50,000 common shares upon conversion of a convertible debenture, 3,836,757 common shares to Green Shift Commodities Ltd., and 1,000,000 common shares to Consolidated Uranium Inc., all under a Section 4(a)(2) exemption. The board appointed independent directors Janet Meiklejohn and Tomas De Pablos Souza and adopted the Jaguar Uranium Corp. 2025 Equity Incentive Plan.